E Coli Testing Market | Contrive Datum Insights

The E.Coli test market size was $1.75 Billion in 2022 and is projected to reach $3.29 Billion by 2030, growing at a CAGR of 7.24% from 2022 to 2030.

E-Coli Testing Market Overview

Escherichia coli or E. coli is designated as a bacterium that normally lives in the intestines of humans and animals. There are certain types of E. coli that are an important part of a healthy human intestinal system. In addition, others are pathogenic and may cause illness or diarrhea. The resulting diarrhea can spread through contaminated water and food, and even through contact with animals or other people. There are many kinds of pathogenic Escherichia coli, which are classified according to pathogenic type. Almost six pathogenic E. coli species are associated with diarrhea and are known as diarrhoeagenic E. coli. The main signs and symptoms of E. coli infection are diarrhea, abdominal pain, and nausea and vomiting. Cases of E. coli infection are usually confirmed by testing for the bacteria in a stool sample from an infected person. It is mainly found in contaminated food or contaminated water, including untreated drinking water and the feces of infected people. In addition, this bacterium is also present on the surface of animals, mainly sheep, cattle and goats.

The E-Coli Testing has recently published by Contrive Datum Insights to its huge database which helps to shape the future of the businesses by making well-informed business decisions. It offers a comprehensive analysis of various business aspects such as global market trends, recent technological advancements, market size, shares, and new innovations. Furthermore, this analytical data has been compiled through data exploratory techniques such as primary and secondary research. Moreover, an expert team of researchers throws light on various static as well as dynamic aspects of the global E-Coli Testing market.

Some Of the key players study are the

Different leading key players have been profiled to get better insights into the businesses. It offers detailed elaboration on different top-level industries which are functioning in global regions. It includes informative data such as company overview, contact information, and some significant strategies followed by key players: Abbott Laboratories, Bio-Rad Laboratories, Bureau Veritas SA, Enzo Life sciences, Eurofins Scientific SE, F.Hoffmann-LaRoche Ltd, HyServe & Co KG, Idexx Laboratories, SGS SA, Thermo Fisher Scientific., and others.

Industry Development:

• In July 2019, Bio-Rad will launch a test that can accurately detect Shiga toxin-producing E. coli pathogens in food, including meat and poultry. This dd-Check STEC solution utilizes ddPCR technology to distinguish double positive linked, true virulence genes in samples from samples containing single positive or unlinked virulence genes, minimizing false positive Shiga toxin-producing Escherichia coli (STEC ) number of results.
• In January 2016, Thermo Fisher Scientific, Inc. acquired Affymetrix, Inc., a North American-based provider of cell and genetic analysis products. The acquisition may expand the company's existing product portfolio with various applications.

What are the major Applications, Types, and Regions for the E-Coli Testing Market?

By Test

Environmental Test

• Membrane Filtration
• Multiple Tube Fermentation
• Enzyme Substate Method

Clinical Test

• Polymerase Chain Reaction Test (PCR)
• Enzyme Immunoassay Test (EIA)

By End User

• Hospital
• Diagnostic Laboratories
• Physician Offices

E-Coli Testing Market Regional Insights:

North America dominated the E. coli testing market in 2017 and is trending the same during the forecast period. Hygiene awareness, stringent government regulations, presence of all major players in the region are the key drivers for this market in the region. However, Asia Pacific is expected to witness strong growth over the forecast period. This is primarily attributed to the improvement in healthcare infrastructure in the region, government regulation of water purity checks, and concerns of key players in the region.

Geographically, the global E-Coli Testing market has been analyzed in various regions such as North America, Europe, Asia-Pacific, Latin America, Middle East, and India. The global region is dominating this market in the upcoming future.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

E-Coli Testing Market report scope:
Frequently Asked Questions (FAQ) about the E-Coli Testing market:

What is the CAGR of the global E-Coli Testing market?

The E-Coli Testing Market is growing at a CAGR of 7.24% During Forecast Period.

Which region would offer high growth for vendors in the E-Coli Testing market?

North America dominated the E. coli testing market in 2017.

Which Is the Most potential market segment?

By Test

Environmental Test

• Membrane Filtration
• Multiple Tube Fermentation
• Enzyme Substate Method

Clinical Test

• Polymerase Chain Reaction Test (PCR)
• Enzyme Immunoassay Test (EIA)

By End User

• Hospital
• Diagnostic Laboratories
• Physician Offices

Which are the top industry players in the E-Coli Testing market?

Abbott Laboratories, Bio-Rad Laboratories, Bureau Veritas SA, Enzo Life sciences, Eurofins Scientific SE, F.Hoffmann-LaRoche Ltd, HyServe & Co KG, Idexx Laboratories, SGS SA, Thermo Fisher Scientific.